Type your tag names separated by a space and hit enter

Linagliptin does not increase (or decrease) risk of adverse CVD outcomes

Linagliptin does not increase (or decrease) risk of adverse CVD outcomes is a topic covered in the EE+ POEM Archive.

To view the entire topic, please or purchase a subscription.

Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics:

Evidence Central

Citation

Slawson, David C., et al., editors. "Linagliptin Does Not Increase (or Decrease) Risk of Adverse CVD Outcomes." EE+ POEM Archive, John Wiley & Sons, 2019. Evidence Central, evidence.unboundmedicine.com/evidence/view/infoPOEMs/1314679/all/Linagliptin_does_not_increase__or_decrease__risk_of_adverse_CVD_outcomes.
Linagliptin does not increase (or decrease) risk of adverse CVD outcomes. In: Slawson DC, Shaughnessy AF, Ebell MH, et al, eds. EE+ POEM Archive. John Wiley & Sons; 2019. https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1314679/all/Linagliptin_does_not_increase__or_decrease__risk_of_adverse_CVD_outcomes. Accessed April 24, 2019.
Linagliptin does not increase (or decrease) risk of adverse CVD outcomes. (2019). In Slawson, D. C., Shaughnessy, A. F., Ebell, M. H., & Barry, H. (Eds.), EE+ POEM Archive. Available from https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1314679/all/Linagliptin_does_not_increase__or_decrease__risk_of_adverse_CVD_outcomes
Linagliptin Does Not Increase (or Decrease) Risk of Adverse CVD Outcomes [Internet]. In: Slawson DC, Shaughnessy AF, Ebell MH, Barry H, editors. EE+ POEM Archive. John Wiley & Sons; 2019. [cited 2019 April 24]. Available from: https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1314679/all/Linagliptin_does_not_increase__or_decrease__risk_of_adverse_CVD_outcomes.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC T1 - Linagliptin does not increase (or decrease) risk of adverse CVD outcomes ID - 1314679 ED - Slawson,David C, ED - Shaughnessy,Allen F, ED - Ebell,Mark H, ED - Barry,Henry, BT - EE+ POEM Archive UR - https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1314679/all/Linagliptin_does_not_increase__or_decrease__risk_of_adverse_CVD_outcomes PB - John Wiley & Sons DB - Evidence Central DP - Unbound Medicine ER -